<DOC>
	<DOC>NCT00614250</DOC>
	<brief_summary>The primary objective of this study is to assess the activity of 4 escalating doses of AVE0657 in comparison to placebo in patients with Obstructive Sleep Apnea Hypopnea Syndrome.</brief_summary>
	<brief_title>Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Subjects diagnosed with Obstructive Sleep Apnea Hypopnea Syndrome based on International Classification of Sleep Disorders Subjects having been treated by Continuous Positive Airway Pressure, oral appliance during 4weeks prior to randomization Chronic respiratory disease or inadequate respiratory parameters Body Mass Index (BMI) of ≤20 kg/m² or ≥35 kg/m² Surgical procedure to correct apnea within the last three months. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
</DOC>